Addressing an 'Intellectuals Meet' organised in Hyderabad by Telangana BJP, he said that through Operation Sindoor, the government had show...

Gases are vital for modern life. From cooling vaccines to preserving food, their impact is immense. An Indian doctor's early innovation wit...

A groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...

CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...

A rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...

Markets often climb despite worries. In 2020, markets rose before economic recovery became clear. Now, in 2026, a similar pattern emerges a...

A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

India has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Bill Cassidy is the first elected U.S. senator to lose re-nomination since 2012. Former Republican Senator Richard Lugar was the last elect...

The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Mic...

A hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...

Hantavirus Outbreak: A hantavirus outbreak on a cruise ship sparks Covid-19 comparisons. Experts clarify hantavirus is distinct, with limit...

Hantavirus Andes strain update: A deadly Andes strain hantavirus outbreak linked to the MV Hondius cruise ship has resulted in three deaths...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

Moderna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...

Moderna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.